Tetraspanins are transmembrane proteins that modulate multiple diverse biological processes, including signal transduction, cell-cell communication, immunoregulation, tumorigenesis, cell adhesion, migration, and growth and differentiation. Here, we provide a systematic review of the involvement of tetraspanins and their partners in the regulation and function of B cells, including mechanisms associated with antigen presentation, antibody production, cytokine secretion, co-stimulator expression, and immuno suppression. Finally, we direct our focus to the signaling mechanisms, evolutionary conservation aspects, expression, and potential therapeutic strategies that could be based on tetraspanins and their interacting partners.
Conventional B cells-a type of white blood cell-were first defined in 1965 by Cooper (1) . They originate from hematopoietic stem cells in mammalian bone marrow or in the bursa of Fabricius of birds, where they pass through several developmental stages and become IgM + immature B cells capable of recognizing antigen (1, 2) . The immature IgM 
Functions of B Cells
B cells play pivotal roles in the immune system. As outlined in Figure 2 , B cells can promote an immune response through presentation of antigens and production of diverse antibodies, proinflammatory cytokines, and co-stimulators (5) . B cells can also suppress immune responses through a 
GeNeRAL FeATUReS AND FUNCTiONS OF TeTRASPANiNS Structure and evolutionary Conservation of Tetraspanins
Tetraspanins belong to a protein family in which members contain intracellular N-and C-termini, two extracellular domains (EC1 and EC2), and specifically four transmembrane domains ( Figure 3A ; 6, 7) . Each phylum has evolved its own particular tetraspanins with distinction in the variety and abundance in different species. Despite this, the chemical composition of tetraspanins is highly conserved among species with four or more cysteine residues in a highly conserved "CCG" motif in the EC2 domain (8) . There are 33 tetraspanins found in humans ( Tables 1 and 2 ) and most of them preserve the characteristics of the ancient sequence in domain EC2.
General interactions Among Tetraspanins and Their Partners
Tetraspanins act as scaffold proteins to anchor multiple proteinsincluding other tetraspanins, partners of tetraspanins, and other proteins-to one area of the cell membrane, and form a tetraspanin-enriched microdomain (TEM) or tetraspanins web (10, 11) . A recent study with super resolution microscopy provided a close view of TEM and demonstrated that TEM is composed of individual nanoclusters (<120 nm). There are no more than 10 CD53 molecules in a single tetraspanin cluster of CD53. The study also evaluated the distances between the individual clusters, including CD53, CD37, CD81, CD82, and the tetraspanin partners such as CD19 and major histocompatibility complex class II (MHC II) (12) . Based on the sensitivity and stringency to different detergents, the interactions of tetraspanins and partners in TEM were classified into three categories (13, 14) .
This model allows for dynamic and adaptable interactions between tetraspanins and other surface proteins based on a descriptive categorization without correlation to functionality in the living cell. A recent review proposed a new applaudable classification of tetraspanin interactions based on their function in the formation of TEM: interactions (a) necessary to maintain tetraspanin structure, (b) that support tetraspanin web formation, (c) that add functional partners to the web, and (d) that facilitate intracellular events (6) . Three hypothetical models could be postulated to decipher the ways that tetraspanin microdomains enhance or regulate cellular signals and exert effects on fundamental biological processes. One model is that tetraspanins be considered a transmem brane linker connecting and augmenting signal transduction between membrane partners and intracellular-signaling proteins (15) . Another model could propose that tetraspanins are involved in gathering partner membrane proteins which subsequently result in increased avidity and/or enhanced interaction with their ligands (16) . The third hypothesis is that tetraspanins function as regulators by sequestering partners from signal transduction (17) thus preventing inappropriate signals and responses in resting cells. Without favoring any of these models at the present time, we now direct our attention to signal transduction and/or regulation by tetraspanins in immune cells ( Figure 3B ).
interaction of Tetraspanin CD81 and its Partners in B Cell Receptor (BCR) Activation Pathway
In B cells, tetraspanins CD81 interacts with the CD19/CD21 signal-transducing complex to lower the threshold for BCR signaling ( Figure 3B1) . The multiprotein complex BCR consists of two parts: membrane immunoglobulin (Ig) with integral membrane domain, and signal transduction moiety Ig-α/Ig-β (also known as CD79A/CD79B) heterodimer tethered by disul fide bridges (18) . When antigen binds to Ig, Src family kinase-like Lyn phosphorylates immuno-receptor tyrosine-based activation motif residues on the cytoplasmic tails of Ig-α/Ig-β, sequentially recruiting and activating Syk and Btk kinases, then initiating downstream signaling cascades of the Ras-MAPK pathway and PLCγ2 (19) . The CD19/CD21 complex is thought to augment BCR signaling by decreasing the signaling threshold for Tetraspanins present four transmembrane domains (TMs) intracellular N-and C-termini and two extracellular domains (EC1 and EC2). CCG motif is formed with cysteine-cysteine-glycine (marked by red) and two disulfide bonds (marked by black line). (B) Pathways regulated by tetraspanins. (B1) B cell receptor (BCR) activation mediated by CD19-CD81-CD21 complex. Ig-α/β receive signals and are phosphorylated by Src kinase (Lyn, Fyn, or Btk), then recruit Syk kinase for initiating downstream signal pathway PLCγ2, Ras/Raf. Tetraspanin CD81, associated with CD52 and CD82, binds C19/CD21/Leu-13 signal-transducing complex and actives PLCγ2 through PI3K, which lowers the threshold for BCR signaling. (B2) Integrin-mediated cell adhesion. PI4-k, associated with various tetraspanins (CD9, CD63, CD81, CD151, and CD231), interacts with and promotes integrins to modulate cell spread and migration. (B3) T cell-B cell contact (TCR) pathway mediated by tetraspanins CD81, CD82, and CD37. CD4 and CD8 associate with Lck kinase to activate TCR signaling but their interaction with CD81, CD82, and CD37 interferes with phosphorylation of Lck kinase and may inhibit TCR signaling. (B4) Endocytic pathway for antigen presentation. Recognized antigens are internalized, processed, and loaded onto MHC class II molecules during the late endosome stage. Major histocompatibility complex class II mediates transport to the cell surface and the release of exosomes. Tetraspanin microdomains in antigen-presenting cell membranes are enriched for specific peptide-MHC class II complexes, peptide editor human leukocyte antigen-DM, and CD86 among other proteins. This selecting domain probably facilitates antigen presentation and T-cell activation, increasing MHC avidity. B cell activation (20) . Indeed, the direct association of tetraspanin CD81 with CD19 as a part of the CD19/CD21/Leu-13 complex is critical for both assembly and localization of this complex (20) and CD81-deficient B cells have been found to have reduced expression of CD19 and impaired B cell signaling (21) . Furthermore, probably through interaction of tetraspanins CD9, CD53, CD82 with CD81, the CD19/CD21 complex has an additional layer of control over B cell signal regulation through formation of a CD19/CD21 complex with additional functional proteins, such as glutathione and oxidative homeostasis-related enzyme γ-glutamyl transpeptidase GGT (22) .
Function of Tetraspanin/integrin Complexes in Signaling Pathway for Cell Migration and Adhesion
Tetraspanins associating with and forming tetraspanin/kinaseintegrin complexes are implicated in both leukocyte and cell-cell adhesion ( Figure 3B2 ) by causing signal activation and cytoskeletal reorganization. In B cells, by enhancing tyrosine phosphorylation levels, tetraspanin CD9 promotes β1 integrin-dependent mobility (23) . In addition, tetraspanins CD9 as well as CD63, CD81 have been documented to associate with both PI4-kinase and integrin α3β1 in lymphoid cell lines (24) . Finally, tetraspanins also have been found to enhance the avidity of integrins for neutrophil motility and T cell-B cell contact (25) .
Function of Tetraspanin CD37 and its Partners in T Cell-B Cell Contact (TCR) Activation Pathway
Tetraspanins are implicated in TCR-induced activation and proliferation ( Figure 3B3) . Interaction of peptide with the MHC activates the TCR and initiates the downstream signaling cascade of Src kinases Fyn and Lck. Lck subsequently activates the functional proteins involved in T cell activation and proliferation.
Interaction of Lck with CD4/CD8 plays crucial roles in this pathway (20) ; should CD4 associate with tetraspanins CD81/82 then Lck is sequestered from the TCR signaling pathway (26) . Additional evidence shows that tetraspanin CD37 is coupled to TCR signal transduction mostly by influencing the dynamics of CD4-Lck distribution to TCR signal associated microdomains (27) . Thus, tetraspanins regulate the T cell biologic process by influencing the TCR-CD4/CD8 cascade proximal to Lck mobilization.
Functions of Tetraspanins and Their Partners in Antigen-Presenting Processes
MHC avidity and facilitation of T cell activation is also mediated by tetraspanins ( Figure 3B4 ). Tetraspanins function in antigen-presenting cells (APCs) to assist in the presentation of the MHC-peptide complex to T cells. Tetraspanins CD81, CD37, CD82, CD53, and CD63, tether with MHC and associate with stimulators on exosome vesicles which are MHC II-enriched compartments. After the cell membrane is fused with MHC, the exosomes are released and can act as stimuli for T-cell proliferation (28) . But there is an additional way in which tetraspanins work with MHC. Tetraspanin microdomains are enriched for MHC II, CD86, and the class II editor human leukocyte antigen in the membrane of APCs. This complex is referred to as the "CDw78 + microdomain" involved in T cell activation (20) . Through the above-enumerated regulatory pathways, the TEMs form a web for signal transduction from extracellular stimuli to intracellular-signaling components and ultimately regulate multiple biological processes, including cell activation, proliferation, adhesion, migration, and communication, as well as involvement in pathological conditions, such as autoimmune diseases, metastasis, and viral infection (Table S2 in TSPAN3,  TSPAN13, CD53, CD37, CD82, CD81, CD63, and TSPAN33 show relatively high levels of mRNA (TPM > 10). TSPAN2, 5, 10, 14, 17, 31, and 32, and UPK1B, ROM1, CD151, and CD9 have detectable mRNA transcripts. But the remaining tetraspanins have no detectable mRNA. In addition, the expression of all tetraspanins except TSPAN19 is detectable in at least one strain of B cell lymphoma cell lines. More expression profiles of tetraspanins can be found in Figure 4 and Table 2 .
expression of Tetraspanin Partners on the Surface of B Cells
Affinity capture assays, protein-fragment complementation assays, and two-hybrid tests in the databases of BioGRID (Table  S3 in Supplementary Material) and ingenuity pathway analysis ( Table 1 ; Table S2 in Supplementary Material) have allowed for the identification of hundreds of tetraspanin interacting partners. The main cell surface partner proteins of tetraspanins are other tetraspanins, integrins, G-protein coupled receptors, and transmembrane receptors like CD19. After removal of the partners expressed in the cytoplasm and the nucleus, there are 93 membrane proteins which potentially interact with extracellular tetraspanins or tetraspanins on the same membrane (Table S3 in Supplementary Material). Some of the tetraspanins which interact with other tetraspanins include CD151, CD37, CD53, CD63, CD81, CD82, CD9, ROM1, TSPAN2, TSPAN3, and TSPAN12 (Table S3 in 
FUNCTiONS OF TeTRASPANiNS iN B CeLLS
Tetraspanins modulate cell adhesion, migration, and invasion which are strongly involved in cancer development and progression (29) . The association between tetraspanin expression and cancer prognostic is found in many kinds of cancers ( Table 1) . In B lymphoma, aberrant expression of CD9, CD81, and CD82 was linked to B-acute lymphoblastic leukemia (30) (31) (32) . Increased CD37 expression was found in B cell malignancies and thus CD37 antibodies were developed to deplete malignant B cells for the treatment of chronic lymphocytic leukemia (33) . The correlation of tumorigenesis and tetraspanins is discussed in another submission for this topic, so here we focus on the functions of tetraspanins and their partners on normal B cell biology without any further discussion of B cell malignancy. Functions of tetraspanins are summarized in Figure 6 and Table 3 .
Act as Markers identifying B Cell Subsets
As discussed above (Figure 4; Table 2 ), since some tetraspanins are enriched in specific B cell subsets, they may be used as markers to identify B cell subsets or diagnostic markers for certain diseases. CD9 is reported to be a special shared marker by B-1 cells, MZB cells, and plasma cells in mice. A study demonstrated that CD9 is expressed by plasma cells in response to antigens independent or dependent on T cells, suggesting CD9 is acquired by T cell dependent plasma cells (34) . Another study demonstrated that CD9 is a cell surface marker for precursors of human plasma cells in germinal centers. It is based on the evidence that (1) compared to CD9 − cells, CD9 + B cells show higher Blimp-1 but lower Bcl-6 and Pax-5 protein levels, and a faster process of differentiation into plasmablasts in the presence of PC-generating cytokines; (2) expression of CD9 was induced and gradually increased in CD9 − GC-B cells under PC generating condition (35) . A recent study showed that murine CD9 is a unique cell surface marker identifying IL-10 competent Bregs and their progenitors (36) .
Roles in Cell Activation, Proliferation, Survival, and Development
The CD21/CD19/CD81 complex modulates signal transduction events pivotal for development of B lymphocyte and the normal function of humoral immunity. As shown in Figure 1 , CD19, a hallmark of B cells, is sustained in its presence on B cells from the earliest pro-B cell stage to plasmablasts during development. CD19 functions as a co receptor of B cells in association with CD21 and CD81. In the complex, CD19 is the signaling molecule bound by Src-family kinases and PI-3 kinase, CD21 binds opsonized foreign antigens, and CD81 is associated with other tetraspanins including CD82, CD63, CD53, and CD9 to enable formation of TEMs (43) . CoIP experiments demonstrated association of CD9, CD81, and CD82 with CD19 and digitonin treatment disrupted the CD9/CD19 and CD9/CD81 associations but not the CD81/CD19 association, implying that the association of CD9 with CD19 is through CD81 instead of another molecule. Different proteins including CD19 could be tyrosine phosphorylated which is induced by engagement of CD9, suggesting that CD9 involves B cell activation and differentiation (37) . CD81 is one of the key proteins participating in controlling homeostasis of lymphocytes through modulating their proliferation. CD81 KO mice show reduced B1 cells and CD19 expression on B cells although the development of T cells and conventional B cells is normal. Moreover, in CD81 KO mice, the proliferative response of T cells is enhanced following TCR engagement, while proliferation of B cell responding to BCR cross-linking is severely impaired (21) . Engagement of CD81 with hepatitis C virus (HCV) envelope protein E2 could protect B cells from apoptosis (56) , and induce B cell activation (57, 58) and VH hypermutation (59) . CD9 appears to function in B cell activation and differentiation based on its expression in specific B cell subsets and its functional interaction with CD19. CD9 is reported as a cell surface marker of B-1 B cells, MZ B cells, and plasma cells, but the development of these B cell subsets as well as the humoral immune responses to antigens appear to be normal when CD9 is knocked out (60) . A recent study also confirmed that most of the tested markers expressed on total B cells are not significantly altered when CD9 is mutated. Interestingly, however, the frequency of occurrence of IL10 competent Breg (B10 cells) is increased and CD23 expression is reduced on B10 cells when CD9 is knocked out (36) . Moreover, CD9 is reported to facilitate interacting with human follicular dendritic cells through the VLA4/VCAM-1 axis and contribute to the survival of germinal center B cells (38) . In addition to its involvement in Ig production, CD53 also contributes to B cell differentiation. A study demonstrated that CD53 is a direct genetic target of EBF-1, a critical transcription factor in early B lymphocyte development. CD53 has functional binding sites for EBF-1 in its promoter elements and can be induced by ectopic expression of EBF-1 (45) . CD53 transcripts are enhanced significantly by mitogenic stimulation, implying that CD53 may be involved in the transport of signals important for cell proliferation. Under conditions of serum deprivation, ligation of CD53 in B lymphoma cells triggers an AKT-mediated survival response and prompts a significant reduction in caspase activation and the number of cells that enter apoptosis (61) . By using live-cell imaging and gene knockout mice, a recent study demonstrated that CD53 is specifically required for the recruitment of PKCβ (the protein kinase C family member) from cytosol to CD53-enriched TEMs on the plasma membrane to activate PKCβ for antigen-dependent BCR activation, suggesting that TEMs act as signaling hotspots (46) .
The tetraspanin CD37 has profound roles in B cell proliferation and survival. CD37 regulates the plasma membrane distribution of α(4)β(1) integrins by controlling their mobility and clustering, a necessary step in activating Akt survival pathways. It is reported that the number of IgG-secreting plasma cells is reduced in lymphoid organs when CD37 is knocked out in mice, possibly due to the impaired association of VCAM-1 to the α(4)β(1) integrin for the Akt survival pathway with the corollary of increased apoptosis of plasma cells in germinal centers (51) . In a recent study, CD37 knockout in mice can drive B cell lymphoma progression through constitutive activation of the IL6 pathway by losing the control of suppressor of cytokine signaling 3 (54) . Although CD37 is crucial for B cells to survive and provide long lasting immune protection, another study reported that CD37 may trigger a cascade of events resulting in apoptosis when it is tyrosine phosphorylated and binds with signaling factors. The study also found that CD37 mediates SHP1-dependent death via its N-terminal domain, whereas it antagonizes death signals through the C-terminal domain by mediating PI3K-dependent survival (52) .
CD82 associates with MHC-I at the cell surface of B cells and could interfere with the capacity of the MHC-I complex to protect targets from NK-mediated cytotoxicity (55) . CD63 is reported as a suppressor of exosome production and could regulate exosome-mediated MHC II-dependent T-cell stimulation (48) .
Roles in Antibody Production
In addition to its role in B cell proliferation and selection of IgG + plasma cells, CD37 promotes IgG1 production while inhibiting IgA immune responses in vivo. CD37 deficiency causes a reduction of serum IgG1 levels and alters B cell responses to T cell-dependent antigen under suboptimal costimulatory conditions (62) . Besides the reduction in serum IgG1 levels, CD37 deficiency in B cells causes high levels of IL-6 and is directly responsible for the increased IgA + plasma cell numbers and IgA production levels in CD37 −/− mice. CD37 −/− mice are better protected from infection by Candida albicans than WT mice due to the increased C. albicans-specific IgA antibody levels. Neutralization of IL-6 in vivo could reverse the enhanced IgA response in CD37 −/− mice (63) . Therefore, it is not surprising to find that CD37 protects against the development of IgA nephropathy by controlling the formation and deposit of IgAantigen complexes in the glomerulus (53) .
The absence of CD81 on murine B cells causes a defect of antibody responses to T cell-dependent protein antigens and reduces the production of IL-4 that is specific to antigens in both spleens and lymph nodes. A putative ligand on a subpopulation of B and T cells may interact with CD81 to signal IL-4 production (41). The function of CD81 was confirmed in a patient carrying a homozygous mutation of the CD81 gene which caused the syndrome of antibody deficiency by disrupting the CD19 complex in B cells and impairing BCR activation although the CD19 alleles in the patient are normal. Otherwise, the patient had neither overt T cell subset nor functional defects, similar to CD19-deficient patients. Further study revealed that CD19 membrane expression critically depends on CD81 and no cell surface CD19 could be observed on B cells from the patient who had the mutated CD81 (42) .
Besides the above proteins, CD53 also plays an important role in activation and differentiation of B cells. CD53 engagement with both the MEM-53 antibody against CD53 and a polyclonal anti-mouse immunoglobulin promotes B cell activation from resting status into the G1 phase, and induces Ig production when treated with T cell supernatant (47) . 
Roles in virus infection
Both CD9 and CD63 were identified and found to be transcribed by IgM + cells in different tissues of rainbow trout (Oncorhynchus mykiss). And the abundance of CD9 transcripts decreased significantly in IgM + splenocytes when the cells were exposed in vitro to viral hemorrhagic septicemia virus (64) . Overexpression of CD9 caused a significantly higher yield of extracellular vesicles and improved the speed and efficiency of lentiviral gene delivery into T and B cells with the lentivirus produced in the CD9 high cells, although the virus titers were not increased. The study indicates an important role for CD9 in membrane fusion, virus infection, and information transfer mediated by extracellular microvesicles (40) .
Viral oncogene latent membrane protein 1 (LMP1) accumulates within intraluminal vesicles to avoid degradation and thus constitutively activates NF-κB which is important for EBV persistence in B cells. CD63 associates with LMP1 and facilitates the inclusion of LMP1 into vesicles lacking MHC II. Preclusion of LMP1 assembly within CD63-enriched domains by C-terminal modifications of LMP1 leads to NF-κB overstimulation. Interference through shRNAs against CD63 causes redistribution of LMP1 and leads to a dramatic increase in LMP1-induced NF-κB activity, indicating that CD63 is sensitized to and controls LMP1-mediated NF-κB activation (49) .
CD81 plays important roles in HCV infection by acting as a HCV entry factor (65), promoting HCV RNA replication (66) , and reducing HCV-induced immune responses (44) . B cells expressing CD81 can be infected by HCV and serve as reservoirs for chronic HCV infection (67) .
Cell Migration, Adhesion (50) . It is reported that CD53 plays an important role in homotypic cell aggregation of lymphocytes and may interfere with lymphocyte activation and cell adhesion. HI29, an anti-CD53 monoclonal antibody, was able to induce homotypic cell aggregation in a B cell strain from a leukocyte adhesion deficiency patient. Moreover, pre-incubation with MEM53, another antibody against CD53, can block such aggregation but anti-CD44 or anti-CD49d mAbs have no blocking effects. Tetraspanins also interact with integrins which function within the area of cellular motility. Ectopic expression of CD9 has been reported to enhance B cell migration via interacting with integrins α6β1 and α4β1 (23) . α4β1 on B cells can also be associated with CD81 (68).
FUNCTiONS OF TeTRASPANiN PARTNeRS eXPReSSeD ON B CeLLS
The partners of tetraspanins have multiple functions in B cellsincluding regulation of B cell activation, survival, development, antibody production, virus infection, and signal transductionthrough mechanisms which may not be correlated with the interaction between tetraspanins and the partners. More details can be found in Table 4 .
THeRAPY STRATeGieS FOR iMMUNe DiSeASeS CORReLATeD wiTH TeTRASPANiNS AND THeiR PARTNeRS
Most studies on employing tetraspanins and their partners as therapy target of diseases involve cancer treatments, a subject outside the scope of this review. For other diseases, there are some strategies using tetraspanins and their partners on B cells as therapy targets, as we explain below.
Depletion of B Cell Subsets, Blockade of Receptors or Crosslinking with Antibodies Against Certain Tetraspanins or Partners CD21 can be used as a target for depletion of EBV positive B cells as it is a receptor for EBV on B cells. CD19 is a hallmark of B cells and could be used as a target for B cell depletion in the treatment of autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus (SLE). There is a phase I clinical trial (Identifier: NCT00639834, ClinicalTrials.gov) using anti-CD19 antibody MDX-1342 together with methotrexate for the treatment of patients with rheumatoid arthritis.
CD81 is an entry factor for HCV infection. Monoclonal antibodies with high affinity to CD81 are generated for prevention of HCV infection (108) . TNFRSF17/BCMA is preferentially expressed in CD180 − B cells which produce autoantibodies and are significantly increased in SLE (104, 105, 109) . TNFRSF17/BCMA and CD180 − B cell subsets would be ideal targets for SLE treatment. CD44 engagement could control CD40L-mediated polyclonal B cell activation (88) . Cross-linking of CD53 with antibodies against CD53 promotes activation of resting B cells, speeds up the entrance into the G1 phase of cell cycle, and induces Ig production during the incubation with T cell supernatant (47) .
Reduction of Protein Abundance with shRNAs or siRNAs Against Certain Tetraspanins or Partners
Interference through shRNAs against CD63 causes redistribution of LMP1, leads to a dramatic increase in LMP1-induced NF-κB activity, and would benefit treatment of EBV infection (49) .
Overexpression or Delivery of Certain Tetraspanins or Partners in B Cells
CD9 expression increases exosome production and promotes lentivirus infection (40) , thus CD9 could be overexpressed in the engineered cells producing therapeutic exosomes to enhance the yield of exosomes and the delivery efficiency of exosomes.
interference of Tetraspanins or Partners with Small Molecules, inhibitors, or Stimulators of Diseases ADAM10 improves IgE production via its sheddase activity on CD23, an IgE receptor with low affinity (70) . Adam10 increases in the B cells of allergic patients and Th2 prone mice (71) and would help diagnostically in predicting Th2 disease susceptibility. ADAM10 inhibitors could be used for attenuating allergic diseases.
immunotherapy with Certain B Cell Subsets Defined by Specific Tetraspanins or Partners IL-10 secreting Breg defined by CD19 and CD9 in mouse (36) or CD19, CD27, and CD38 in human (4) could be enriched, expanded, and then adoptively transferred for treatments of autoimmune diseases. 
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